Elrexfio 00069-2522
Generic: Elranatamab-Bcmm
Product NDC
00069-2522- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 15, 2023
- Listing Expires
- December 31, 2027
- Application
- BLA761345
Need to source Elrexfio? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Elranatamab | 44 mg/1.1mL |
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (0069-2522-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (0069-2522-01)